نتایج جستجو برای: radiochemotherapy

تعداد نتایج: 1049  

2014
Philippe Rochigneux Michel Resbeut Frédérique Rousseau Erwan Bories Jean-Luc Raoul Flora Poizat Laurence Moureau-Zabotto

BACKGROUND Although the prevalence of esophageal cancer increases in elderly patients, its clinical history and outcome after treatment remain poorly described. METHODS Between January 2001 and December 2011, 58 patients (pts) older than 75 years received 3D-conformal radiotherapy (mean dose 51 Gy) in two French cancer centers. 47/58 (82%) patients received concomitant chemotherapy (with CDDP...

2016
Matthias Riedel Nina Struve Justus Müller-Goebel Sabrina Köcher Cordula Petersen Ekkehard Dikomey Kai Rothkamm Malte Kriegs

BACKGROUND Glioblastomas (GBM) are the most common malignant type of primary brain tumor. GBM are intensively treated with surgery and combined radiochemotherapy using X-irradiation and temozolomide (TMZ) but they are still associated with an extremely poor prognosis, urging for the development of new treatment strategies. To improve the outcome of GBM patients, the small molecule multi-kinase ...

2016
Aurélie Bertaut Caroline Truntzer Rachid Madkouri Coureche Guillaume Kaderbhai Valentin Derangère Julie Vincent Bruno Chauffert Marie Hélene Aubriot-Lorton Wahlid Farah Klaus Luc Mourier Romain Boidot Francois Ghiringhelli

Bevacizumab is used to treat glioblastoma; however, no current biomarker predicts its efficacy. We used an exploratory cohort of patients treated with the radiochemotherapy then bevacizumab or chemotherapy at recurrence (N = 265). Bevacizumab use increased median overall survival (OS) 18.7 vs 11.3 months, p = 0.0014). In multivariate analysis, age, initial surgery, neutrophil count, Karnofsky s...

2017
Kaiyan Fu Hongying Pan

Colorectal cancer is one of the most common malignancies in China and worldwide. Neoadjuvant radiochemotherapy has inspiring therapeutic effect in treating colorectal cancer with high risk of recurrence. However, malnutrition is prevalent in patients with colorectal cancer and causes clinical deterioration. To investigate the impact of neoadjuvant radiochemotherapy on the nutritional status of ...

Journal: :PloS one 2016
Afshin Teymoortash Andreas Pfestroff Andrea Wittig Nora Franke Stephan Hoch Susanne Harnisch Carmen Schade-Brittinger Helmut Hoeffken Rita Engenhart-Cabillic Markus Brugger Konstantin Strauch

This prospective, randomized, placebo-controlled, double-blinded phase I clinical trial investigates safety and efficacy of botulinum toxin (BoNT) to preserve gland function after radiotherapy in patients with head and neck cancer. Twelve patients with advanced head and neck cancer were injected with BoNT into the submandibular glands prior to primary radiochemotherapy. Six patients received Bo...

Journal: :Annals of oncology : official journal of the European Society for Medical Oncology 2004
L Trodella P Granone S Valente S Margaritora G Macis A Cesario R M D'Angelillo V Valentini G M Corbo V Porziella S Ramella G Tonini D Galetta M Ciresa B Vincenzi N Cellini

BACKGROUND To report the efficacy of induction treatment (IT) protocol with concurrent radiochemotherapy in locally advanced non-small-cell lung cancer (NSCLC), and to analyze downstaging as a surrogate end point. PATIENTS AND METHODS Patients with histo- or cytologically confirmed stage IIIA or IIIB NSCLC were treated according to an IT protocol followed by surgery. Downstaging was assessed ...

2015
Erika Crosetti Andrea Fulcheri Giovanni Succo

INTRODUCTION We present a rare case of pharyngo-jugular fistula in a patient who underwent salvage total laryngectomy after organ-sparing radiochemotherapy. CASE PRESENTATION A 77-year-old Caucasian man underwent total laryngectomy and bilateral neck dissection as salvage surgery after the failure of radiochemotherapy at another hospital. Thirty-five days after surgery, he was admitted to our...

Journal: :Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique 2017
S Lévy S Chapet N Scher K Debbi A Ruffier G Bernadou Y Pointreau G Calais

PURPOSE To search for factors correlated with relapse-free survival following stereotactic reirradiation in patients with recurrent glioma following radiochemotherapy and evaluate tolerance to this treatment. PATIENTS AND METHODS Initial radiotherapy was given according to the protocol of Stupp and al. Reirradiation was performed using the CyberKnife® system. Patients could have had surgical ...

2005
Martin Dreyling Georg Lenz Eva Hoster Achiel Van Hoof Christian Gisselbrecht Rudolf Schmits Bernd Metzner Lorenz Truemper Marcel Reiser Hjalmar Steinhauer Jean-Michel Boiron Marc A. Boogaerts Ali Aldaoud Vittorio Silingardi Hanneke C. Kluin-Nelemans Joerg Hasford Reza Parwaresch Michael Unterhalt Wolfgang Hiddemann

Mantle-cell lymphoma (MCL) is characterized by poor prognosis with a median survival of only 3 to 4 years. To improve clinical outcome, the European MCL Network initiated a randomized trial comparing consolidation with myeloablative radiochemotherapy followed by autologous stem cell transplantation (ASCT) to interferon maintenance (IFN ) in first remission. Patients 65 years of age or younger w...

2016
Nuno Sousa Olga Sousa Lúcio Lara Santos Rui Henrique Manuel R. Teixeira Mário Dinis-Ribeiro Armando Teixeira-Pinto

BACKGROUND Preoperative radiochemotherapy followed by surgical removal of the rectum with total mesorectum excision is the preferred treatment option for stages II and III rectal cancer. However, development of metastatic disease is the main cause of death for these patients with 5-year disease-free survival rates of 56 %. Anti-epidermal growth factor receptor (EGFR) targeted therapy is effecti...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید